Complete Confidence:
The Alcon Advantage
IOL Options for Every Patient
Complete Confidence: The Alcon Advantage
IOL Options for Every Patient
AcrySof IQ Vivity® IOL
Simplifying presbyopia correction on Alcon's advanced lens platform.1-10
Clareon® PanOptix® IOL
PanOptix® delivers an excellent high-quality visual experience from far to near, with 99% patient satisfaction and over 2.2 million implants worldwide.11-15
AcrySof® IQ Monofocal IOL and AcrySof® IQ Toric IOL
The trusted IOLs that give you confidence.13
Clareon® Monofocal IOL and Clareon® Toric IOL
Our advanced lens platform that delivers pristine visual outcomes.10,16,17
Alcon Experience Academy
For relevant training content from industry thought leaders
References:
1. Clareon® Vivity® Extended Vision IOL Directions for Use.
2. Alcon Data on File, 2018. US Patent 9968440 B2.
3. Bala C, et al. Multi-country clinical outcomes of a new nondiffractive presbyopia-correcting intraocular lens. J Cataract Refract Surg. 2021: Ahead of print. doi:10.1097/j.jcrs.0000000000000712.
4. Alcon Data on File, 2019. TDOC-0055576.
5. Alcon Data on File, 2019. TDOC-0056718.
6. Ligabue E, et al. ACRYSOF IQ VIVITY: Natural vision at a range of distances provided by a novel optical technology. Cataract & Refractive Surgery Today. April 2020.
7. Alcon Data on File. A02062-REP-043696, Optical Evaluations of Alcon Vivity®, Symfony*, and Zeiss* AT LARA* IOLs.
8. Lawless M. Insight news. “An IOL to change the cataract surgery paradigm?” available at “https://insightnews.com.au/an-iol-to-change-the-cataract-surgery-paradigm/”. Accessed 17 Jul 2020.
9. Ahmed I, et al. The Vivity Extended Depth of Focus IOL: Our Clinical Experience. Cataract & Refractive Surgery Today. February 2021//.
10. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497.
11. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.
12. Zhu et al. Rate of Complete Spectacle Independence with a Trifocal IOL (PanOptix): A Systematic Literature Review and Meta-Analysis. Presentation at 2022 ASCRS; April 2022; Washington, D.C.
13. Market Scope 2022 IOL Market Report.
14. Alcon Data on File, 2022. [REF-18881].
15. Clareon® PanOptix® Trifocal IOL Directions for Use.
16. Clareon® IOL Directions for use.
17. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.
Please refer to relevant products DFU or Operator’s manuals for complete list of indications, contraindications and warnings.
AcrySof IQ Vivity IOL GC7500820-45139
AcrySof IQ GC22179146917
AcrySof IQ Toric GC41940206117
Clareon Aspheric Hydrophobic Acrylic IOL GC257181062818
Clareon Toric IOL GC7866820-45138
Clareon PanOptix Trifocal Hydrophobic IOL GC5854320-49547
Clareon PanOptix Toric Trifocal Hydrophobic IOL GC3248421-74906
Registered under Act 737
The content is intended for Healthcare Professionals only, not for general public
